Article
Validation of p53 immunohistochemistry as a prognostic factor in breast cancer in clinical practice.
Archives of pathology & laboratory medicine - 1 Apr 2002
Bartley Angela N, Ross Dennis W
Abstract excerpt
CONTEXT: Abnormal p53 tumor suppressor gene expression as detected by immunohistochemistry is a possible prognostic factor in breast cancer. The difference in techniques used to evaluate the expression of mutated p53 protein is under intense scrutiny, as well as its uses either independently or in conjunction with other prognostic factors in breast cancer. OBJECTIVE: To determine whether p53 immunohistochemistry...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
